Day: October 6, 2020

FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay to Include COVID-19 Testing of Asymptomatic Individuals, Symptomatic Sample Pooling

MARLBOROUGH, Mass.--(BUSINESS WIRE)--#COVID19--Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA)...

PQ Bypass Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease

FDA-designated Breakthrough Device now one step closer to PMA submission MILPITAS, Calif.--(BUSINESS WIRE)--#ClinicalTrial--PQ Bypass, an innovative medical device company pioneering...

error: Content is protected !!